When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PFE - Astellas' Xtandi OK'd in Japan for new prostate cancer indication
Pfizer Inc.
Japan's Ministry of Health, Labor and Welfare approves Astellas Pharma's (OTCPK:ALPMF) Xtandi (enzalutamide) for the treatment of prostate cancer patients with distant metastases.
More news on: Astellas Pharma Inc., Pfizer Inc., Astellas Pharma Inc., Healthcare stocks news,